GFACX
Price
$66.58
Change
-$0.13 (-0.19%)
Updated
Sep 20 closing price
KLCCX
Price
$16.17
Change
-$0.00 (-0.00%)
Updated
Sep 20 closing price
Ad is loading...

GFACX vs KLCCX

Header iconGFACX vs KLCCX Comparison
Open Charts GFACX vs KLCCXBanner chart's image
American Funds Growth Fund of Amer C
Price$66.58
Change-$0.13 (-0.19%)
VolumeN/A
CapitalizationN/A
Federated Hermes Kaufmann Large Cap C
Price$16.17
Change-$0.00 (-0.00%)
VolumeN/A
CapitalizationN/A
View a ticker or compare two or three
GFACX vs KLCCX Comparison Chart
Loading...
VS
GFACX vs. KLCCX commentary
Sep 21, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GFACX is a StrongBuy and KLCCX is a StrongBuy.

FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 290B vs. KLCCX (1.53B). GFACX (0.00) and KLCCX (0.00) have matching dividends . GFACX was incepted earlier than KLCCX: GFACX (24 years) vs KLCCX (17 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. KLCCX (19.00). GFACX has a lower initial minimum investment than KLCCX: GFACX (250) vs KLCCX (1500). GFACX annual gain was more profitable for investors over the last year : 21.68 vs. KLCCX (-12.08). GFACX return over 5 years is better than : 42.36 vs. KLCCX (-35.88).
GFACXKLCCXGFACX / KLCCX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence24 years17 years-
Gain YTD18.67315.160123%
Front LoadN/AN/A-
Min. Initial Investment250150017%
Min. Initial Investment IRAN/AN/A-
Net Assets290B1.53B19,004%
Annual Yield % from dividends0.000.00-
Returns for 1 year21.68-12.08-180%
Returns for 3 years-7.22-54.4713%
Returns for 5 years42.36-35.88-118%
Returns for 10 years47.07-9.71-485%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
BVS11.690.32
+2.81%
Bioventus
SMAR51.65-0.12
-0.23%
Smartsheet
ADV3.89-0.02
-0.51%
Advantage Solutions
AJG291.18-4.76
-1.61%
Arthur J Gallagher & Co
LVTX1.68-0.08
-4.55%
LAVA Therapeutics NV